Revcovi
NDC 10122-502, elapegademase-lvlr, injection, from Chiesi USA, Inc..
- Product NDC
- 10122-502
- Status
- Listed
- Labeler
- Chiesi USA, Inc.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761092
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10122-502 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELAPEGADEMASE1.6 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10122-502-01 | 10122050201 | 1 VIAL in 1 CARTON (10122-502-01) / 1.5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8c073f84-cdd0-40e4-b3a9-172687267f28
Use it
Look up 10122-502 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10122-502 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10122-502. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.